| Name | Title | Contact Details |
|---|
Powering the next generation of sustainable brands. Our software reduces the cost and complexity of bringing sustainable and carbon neutral products to market.
We`re a family-owned business from Maine – home to moose, bears, lighthouses, rocky shores, and the perfect ecosystem for a remarkable fruit to grow in abundance: the Wild Blueberry.
Once Upon a Farm is a California-based company with a big dream: to provide yummy and nutritious “farm-to-family” foods to kids of all ages.
JBS USA Holdings, Inc. is an American food processing company and a wholly owned subsidiary of the multinational company JBS SA The subsidiary was created when JBS entered the US market in 2007 with its purchase of Swift & Company.
Neptune is a biotechnology company engaged primarily in the development and commercialization of marine-derived omega-3 polyunsaturated fatty acids ("PUFAs"). Neptune has a patented process of extracting oils from Antarctic krill, and principally sells omega-3 PUFAs as bulk oil to Neptune`s distributors who commercialize them under their private label primarily in the U.S., European and Australian nutraceutical markets. Neptune`s products generally come in bulk oil or capsule form and serve as a dietary supplement to consumers. Neptune`s head office is located at 545 Promenade du Centropolis, Suite 100, Laval, Quebec. Neptune respectively holds approximately 49% of the participating and voting rights of Acasti and 96% of the voting rights of NeuroBio. Through these subsidiaries, Neptune is also pursuing opportunities in the medical food and prescription drug markets. Acasti and NeuroBio respectively focus on the research and development of safe and therapeutically effective compounds for highly prevalent atherosclerotic conditions, such as cardiometabolic disorders and cardiovascular diseases, and for neurodegenerative and inflammation related conditions. Acasti`s lead prescription drug candidate is CaPre(R), a purified high omega-3 phospholipid concentrate derived from Neptune krill oil being developed to address the prevention and treatment of cardiometabolic disorders, including hypertriglyceridemia, which is characterized by abnormally high levels of triglycerides.